Pharmaceutics,
Год журнала:
2025,
Номер
17(4), С. 446 - 446
Опубликована: Март 31, 2025
Background/Objectives:
The
current
research
was
designed
to
quantify
the
active
phyto-constituents
and
investigate
in
vitro
biological
efficiency
of
different
garden
cress
(Lepidium
sativum
Linn.)
seed
extracts
against
chronic
diseases
as
well
vivo
toxicities
that
may
be
induced
mice
upon
administration
each
extract
at
both
studied
therapeutic
doses.
Methods:
L.
extracts,
such
methanolic,
aqueous,
acetone,
ethyl
acetate
assessed.
inhibition
percentage
(%)
median
inhibitory
concentration
(IC50)
values
were
estimated
acetylcholinesterase
enzyme,
diabetes
mellitus
(α-amylase
α-glucosidase
enzymes),
inflammation
(cyclooxygenase-1
(COX-1),
cyclooxygenase-2
(COX-2),
5-lipoxygenase
(5-LOX)
enzymes).
Additionally,
HepG-2,
Caco-2,
A549
cells
assessed
using
3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl
tetrazolium
bromide
(MTT)
assay.
Moreover,
might
hematological
(using
an
automatic
blood
analyzer)
biochemical
levels
evaluated.
Results:
It
found
methanolic
possessed
highest
activities
compared
other
extracts.
51.34,
54.35,
44.10,
43.48,
40.78%
acetylcholinesterase,
α-amylase,
α-glucosidase,
protein
denaturation,
proteinase
enzymes,
respectively.
also
exhibited
effect
COX-1
(55.05%),
COX-2
(57.30%),
5-LOX
(50.15%)
enzymes.
possesses
cytotoxic
activity
cells,
with
IC50
52.27,
40.73,
37.95
μg/mL,
lethal
doses
(LD50)
showed
safer
when
administered
orally,
followed
by
aqueous
then
extract.
acetone
no
alterations
orally
two
(1/10
1/20
LD50)
control.
Conclusions:
This
study
concluded
than
In
future,
efficacy
will
evaluated,
elucidation
its
mechanism
diseases.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 13, 2025
Diabetes
mellitus,
particularly
type
2
diabetes,
is
a
growing
global
health
challenge
characterized
by
chronic
hyperglycemia
due
to
insulin
resistance.
One
therapeutic
approach
managing
this
condition
the
inhibition
of
α-glucosidase,
an
enzyme
involved
in
carbohydrate
digestion,
reduce
postprandial
blood
glucose
levels.
In
study,
series
thiosemicarbazide-linked
quinoline-piperazine
derivatives
were
synthesized
and
evaluated
for
their
α-glucosidase
inhibitory
activity,
identify
new
agents
diabetes
management.
Structure-activity
relationship
(SAR)
analysis
revealed
that
nature
position
substituents
on
aryl
ring
significantly
impacted
potency.
Among
derivatives,
2,5-dimethoxy
phenyl
substitution
(7j)
exhibited
most
potent
activity
with
IC50
value
50.0
µM,
demonstrating
15-fold
improvement
compared
standard
drug
acarbose.
Kinetic
studies
identified
compound
7j
as
competitive
inhibitor,
Ki
32
µM.
Molecular
docking
simulations
demonstrated
key
interactions
between
active
site
while
molecular
dynamics
confirmed
stability
enzyme-ligand
complex,
reflected
low
RMSD
RMSF
values.
JACS Au,
Год журнала:
2025,
Номер
5(2), С. 486 - 520
Опубликована: Фев. 10, 2025
Tetrahedral
framework
nucleic
acids
(tFNAs)
represent
a
promising
advancement
in
acid
nanotechnology
due
to
their
unique
structural
properties,
high
biocompatibility,
and
multifaceted
biomedical
applications.
Constructed
through
one-pot
annealing
method,
four
single-stranded
DNAs
self-assemble
into
stable,
three-dimensional
tetrahedral
nanostructures
with
enhanced
mechanical
robustness
physiological
stability,
resisting
enzymatic
degradation.
Their
ability
permeate
mammalian
cells
without
transfection
agents,
coupled
modifiable
surfaces,
positions
tFNAs
as
versatile
carriers
for
drug
gene
delivery
systems.
The
tFNA-based
platforms
exhibit
superior
therapeutic
efficacy,
including
antioxidative
anti-inflammatory
effects,
alongside
efficient
cellular
uptake
tissue
penetration.
These
features
underpin
role
precision
medicine,
enabling
targeted
of
diverse
agents
such
synthetic
compounds,
peptides,
acids.
Additionally,
demonstrate
significant
potential
regenerative
immune
modulation,
antibacterial
strategies,
oncology.
By
addressing
challenges
translational
integration,
stand
poised
accelerate
the
development
research
clinical
applications,
fostering
novel
therapies
enhancing
outcomes
across
wide
spectrum
diseases.
This
Perspective
thoroughly
details
attributes
applications
critically
evaluates
tFNAs'
potential,
outlining
inherent
implementation
exploring
solutions
these
obstacles.
Foods,
Год журнала:
2024,
Номер
13(15), С. 2437 - 2437
Опубликована: Авг. 1, 2024
The
need
to
increase
food
safety
and
improve
human
health
has
led
a
worldwide
in
interest
gamma-aminobutyric
acid
(GABA),
produced
by
lactic
bacteria
(LABs).
GABA,
from
glutamic
reaction
catalyzed
glutamate
decarboxylase
(GAD),
is
four-carbon,
non-protein
amino
that
increasingly
used
the
industry
safety/quality
of
foods.
In
addition
possible
positive
effects
called
postbiotic,
on
neuroprotection,
improving
sleep
quality,
alleviating
depression
relieving
pain,
various
benefits
GABA-enriched
foods
such
as
antidiabetic,
antihypertension,
anti-inflammatory
are
also
being
investigated.
For
all
these
reasons,
it
not
surprising
efforts
identify
LAB
strains
with
high
GABA
productivity
production
LABs
through
genetic
engineering
yield
accelerating.
However,
GABA's
contributions
have
yet
been
fully
discussed
literature.
Therefore,
this
current
review
highlights
synthesis
applications
LABs,
discusses
its
as,
for
example,
drug
withdrawal
syndromes
regulating
obesity
overeating.
Still,
other
potential
interactions
(among
others)
remain
unanswered
questions
be
elucidated
future.
Hence,
paves
way
toward
further
studies.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
177, С. 117043 - 117043
Опубликована: Июнь 27, 2024
This
study
investigated
the
chemical
constituents,
antioxidant
potential,
and
in
vitro
silico
antidiabetic
activity
of
Gymnema
sylvestre.
Column
chromatography
spectroscopic
techniques
identified
twelve
compounds
from
methanol
extract,
including
4
sterols
(1-4),
5
triterpenoids
(5-9),
3
flavonoids
(10-12).
The
chemophenetic
significance
all
was
also
investigated.
capacity
extract
(1-4)
evaluated
using
FRAP
DPPH
assays.
exhibited
strong
free
radical
scavenging
(IC
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(1), С. 354 - 354
Опубликована: Янв. 3, 2025
Diabetes
mellitus
(DM),
a
global
disease
that
significantly
impacts
public
health,
has
become
increasingly
common
over
time.
In
this
review,
we
aim
to
determine
the
potential
benefits
of
St.
John’s
Wort
(SJW)
as
an
adjunct
therapy
for
DM.
We
gathered
information
from
studies
conducted
in
vitro,
vivo,
and
humans.
vitro
investigated
concentrations
SJW
extracts
capable
inhibiting
certain
enzymes
or
factors
involved
inflammatory
pathway,
such
β-signal
transducer
activator
transcription
1,
nuclear
factor
κB,
methylglyoxal,
oxidative
stress
(OS).
The
extract
was
found
have
positive
effects
on
OS
anti-inflammatory
properties
DM,
suggesting
it
could
serve
protective
agent
against
diabetic
vascular
complications,
cell
damage,
apoptosis.
According
vivo
research,
essential
components
can
stimulate
thermogenesis
adipose
tissue,
inhibit
several
key
signaling
pathways,
delay
early
death
pancreatic
β
cells,
all
which
contribute
combating
obesity.
may
also
help
treat
prediabetes
reduce
neuropathic
pain.
Human
confirmed
some
these
results.
However,
plant’s
side
need
further
investigation
through
clinical
research
before
be
used
This
systematic
review
evaluates
the
comparative
efficacy
of
low-carbohydrate
diets
(LCDs)
versus
low-fat
(LFDs)
in
improving
glycemic
control,
weight
management,
and
lipid
profiles
individuals
with
type
2
diabetes
mellitus
(T2DM)
or
prediabetes.
Seven
randomized
controlled
trials
involving
diverse
populations
were
included,
dietary
interventions
ranging
from
very
ketogenic
(LCK)
(typically
<10%
total
caloric
intake
carbohydrates,
higher
fat
moderate
protein)
to
carbohydrate
regimens
(30-45%
calories).
LFDs,
contrast,
prioritized
(50-60%
calories),
reduced
(<20-30%)
protein
(15-20%).
Across
studies,
LCDs
consistently
demonstrated
greater
reductions
HbA1c,
fasting
glucose,
triglycerides,
alongside
superior
loss
increased
high-density
lipoprotein
cholesterol
compared
LFDs.
Additionally,
associated
significant
medication
use,
highlighting
their
potential
decrease
pharmacological
dependency
improve
metabolic
outcomes,
including
enhanced
insulin
sensitivity
inflammation.
Despite
variability
long-term
outcomes
adherence,
emerged
as
a
promising
alternative
traditional
approaches
for
managing
T2DM.
Further
research
is
warranted
explore
strategies
such
behavioral
technological
support,
evaluate
sustainability,
effects
on
cardiovascular
health
quality
life.
These
findings
underscore
transformative
management
highlight
need
personalized
approaches.
Diabetes-related
cognitive
impairment
is
increasingly
recognized
as
a
significant
complication,
profoundly
impacting
patients'
quality
of
life.
This
review
aims
to
examine
the
pathophysiological
mechanisms,
clinical
manifestations,
risk
factors,
assessment
and
diagnosis,
management
strategies,
future
research
directions
in
diabetes.
A
comprehensive
literature
search
was
conducted
using
PubMed,
Medline,
other
medical
databases
identify,
review,
evaluate
published
articles
on
The
focused
studies
examining
pathophysiology,
presentations,
diagnostic
approaches,
strategies.
current
revealed
that
chronic
hyperglycemia,
insulin
resistance,
vascular
factors
are
major
contributing
deficits
Clinical
manifestations
include
impairments
attention,
memory,
executive
function,
visuospatial
abilities,
language.
Risk
encompass
disease
duration,
glycemic
control,
presence
complications,
age,
education
level,
comorbidities.
Assessment
tools
screening
instruments,
neuropsychological
testing,
neuroimaging
techniques.
Management
strategies
involve
control
optimization,
lifestyle
modifications,
training,
pharmacological
interventions.
highlights
prevalence
impact
diabetes,
resulting
from
complex
metabolic
disturbances.
Early
detection
multifaceted
interventions
crucial
for
preserving
function
improving
patient
outcomes.
Future
should
focus
neuroprotective
biomarker
identification,
personalized
approaches.
Collaborative
efforts
between
clinicians
researchers
essential
effectively
address
this
growing
healthcare
challenge
enhance
life
individuals
with
diabetes-related
impairment.